Comparison of DNA repair and radiosensitivity of different blood cell populations.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 01 2021
Historique:
received: 22 04 2020
accepted: 30 12 2020
entrez: 29 1 2021
pubmed: 30 1 2021
medline: 15 9 2021
Statut: epublish

Résumé

Despite the frequent use of ionising radiation (IR) in therapy and diagnostics and the unavoidable exposure to external radiation sources, our knowledge regarding the radiosensitivity of human blood cell populations is limited and published data, obtained under different experimental conditions, are heterogeneous. To compare the radiosensitivity of different hematopoietic cell populations, we set out to determine the responses of cells obtained from peripheral blood of healthy volunteers under identical conditions (resting, non-stimulated cells). First, we measured the radiation response of T cells (Treg, Th, CTL), B cells, NK cells, CD34+ progenitor cells and monocytes obtained from peripheral blood and monocyte-derived macrophages (Mph) and immature dendritic cells (iDC) ex vivo and show that T and B cells are highly sensitive, starting to undergo apoptosis following IR with a dose as low as 0.125 Gy. Importantly, there was no clear threshold dose and cell death/apoptosis increased up to a saturation level with a dose of 2 Gy. The sensitivity decreased in the order of T cells > NK and B cells > monocytes > macrophages and iDC. The data confirm a previous report that Mph and iDC are radiation-resistant compared to their progenitor monocytes. Although non-stimulated T and B cells were highly radiation-sensitive compared to monocytes and macrophages, they were competent in the repair of DNA double-strand breaks, as shown by a decline in γH2AX foci in the post-exposure period. CD34+ cells obtained from peripheral blood also showed γH2AX decline post-exposure, indicating they are repair competent. Granulocytes (CD15+) did not display any γH2AX staining following IR. Although peripheral blood lymphocytes, the main fraction are T cells, were significantly more radiation-sensitive than monocytes, they displayed the expression of the repair proteins XRCC1, ligase III and PARP-1, which were nearly non-expressed in monocytes. To assess whether monocytes are depleted in vivo following IR, we measured the amount of T cells and monocytes in cancer patients who received total-body radiation (TBR, 6 × 2 Gy). We observed that the number of T cells in the peripheral blood significantly declined already after the first day of TBR and remained at a low level, which was accompanied by an increase in the number of γH2AX foci in the surviving CD3+ T cell fraction. In contrast, the number of monocytes did not decline extensively, reflecting their radiation resistance compared to T cells. Monocytes also showed an accumulation of γH2AX foci in vivo, but the levels were significantly lower than in T cells. CD56+ NK cells displayed a response similar to T cells. The data support the notion that unstimulated T cell subfractions are nearly equally radiation sensitive. There are, however, remarkable differences in the radiation sensitivity between the lymphoid and the myeloid lineage, with lymphoid cells being significantly more sensitive than cells of the myeloid lineage. In the myeloid lineage, macrophages and iDCs were the most radio-resistant cell types.

Identifiants

pubmed: 33510180
doi: 10.1038/s41598-021-81058-1
pii: 10.1038/s41598-021-81058-1
pmc: PMC7843614
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2478

Références

Int J Radiat Biol. 1999 Jun;75(6):767-71
pubmed: 10405007
Front Immunol. 2017 May 03;8:519
pubmed: 28515727
PLoS One. 2017 Jan 18;12(1):e0170347
pubmed: 28099491
Cancer Lett. 2015 Nov 28;368(2):230-7
pubmed: 25888451
Int J Radiat Biol. 1993 Apr;63(4):519-28
pubmed: 8096865
Elife. 2017 Apr 28;6:
pubmed: 28453436
Biochim Biophys Acta. 2014 Aug;1846(1):121-9
pubmed: 24797212
J Innate Immun. 2019;11(1):74-85
pubmed: 30296787
Cancer Res. 2007 Jan 1;67(1):26-31
pubmed: 17210680
Int J Radiat Oncol Biol Phys. 1983 Jun;9(6):829-39
pubmed: 6408037
Radiat Res. 2013 Dec;180(6):603-9
pubmed: 24219325
Blood. 1990 Nov 1;76(9):1867-71
pubmed: 2224134
J Immunol. 2014 Aug 1;193(3):1451-8
pubmed: 24990082
Cell Death Dis. 2018 Oct 15;9(11):1053
pubmed: 30323167
Int J Radiat Biol. 1999 Oct;75(10):1257-64
pubmed: 10549602
J Cell Biol. 2014 Jul 7;206(1):29-43
pubmed: 24982429
DNA Repair (Amst). 2007 Sep 1;6(9):1255-63
pubmed: 17382605
Semin Cancer Biol. 2016 Jun;37-38:51-64
pubmed: 27016036
Radiother Oncol. 2009 Sep;92(3):310-5
pubmed: 19604590
Radiat Oncol. 2009 Nov 26;4:58
pubmed: 19941649
Ann Rheum Dis. 2020 Mar;79(3):e34
pubmed: 30578294
PLoS One. 2012;7(6):e39956
pubmed: 22768182
Front Oncol. 2012 Sep 25;2:120
pubmed: 23057008
Cell. 2002 Apr;109 Suppl:S97-107
pubmed: 11983156
Front Immunol. 2018 Jan 23;8:1933
pubmed: 29410662
Radiother Oncol. 1999 Feb;50(2):199-204
pubmed: 10368044
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21105-10
pubmed: 22160723
Radiat Res. 1990 Aug;123(2):224-7
pubmed: 2117766
Int J Mol Sci. 2018 Nov 13;19(11):
pubmed: 30428512
Cytometry. 1992;13(1):68-74
pubmed: 1372204
J Exp Med. 2017 Jul 3;214(7):1913-1923
pubmed: 28606987
Immunol Rev. 2017 Nov;280(1):231-248
pubmed: 29027224
Mutat Res. 2017 Oct;822:10-18
pubmed: 28844237
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Sci Rep. 2016 Mar 04;6:22682
pubmed: 26940638

Auteurs

Daniel Heylmann (D)

Institute of Toxicology, University Medical Center, Johannes Gutenberg-University Mainz, Obere Zahlbacher Straße 67, 55131, Mainz, Germany.
Rudolf Buchheim Institute of Pharmacology, Justus Liebig University, Giessen, Germany.

Viviane Ponath (V)

Institute of Toxicology, University Medical Center, Johannes Gutenberg-University Mainz, Obere Zahlbacher Straße 67, 55131, Mainz, Germany.
Center for Tumor Biology and Immunology, Institute for Tumor Immunology, Philipps University, Marburg, Germany.

Thomas Kindler (T)

Department of Medical Oncology and Pneumology, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.

Bernd Kaina (B)

Institute of Toxicology, University Medical Center, Johannes Gutenberg-University Mainz, Obere Zahlbacher Straße 67, 55131, Mainz, Germany. kaina@uni-mainz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH